美好醫療系統 MMSI 深 滬
等待開盤 03-26 09:30:00 美东时间
68.11
+0.560
+0.83%
華盛通- 最 高68.821
- 今 開68.43
- 成交量 66.70万股
- 最 低 67.00
- 昨 收 67.55
- 總市值 40.48亿
- 52周最高 100.19
- 市盈率 靜 32.05
- 換手率 1.12%
- 52周最低 66.34
- 委 比 4.08%
- 總股本 5943.19万
- 歷史最高 111.45
- 量 比 0.63
- 振 幅 2.70%
- 歷史最低 9.15
- 每 手 1
- 風險率 7.43%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Medtronic signs distribution deal with Merit Medical for ViaVerte basivertebral nerve ablation system
Medtronic signs distribution deal with Merit Medical for ViaVerte basivertebral nerve ablation system Medtronic entered into an exclusive distribution agreement with Merit Medical to offer the FDA-cleared ViaVerte system for basivertebral nerve ablation in chronic vertebrogenic lower-back pain. ViaV
03-24 20:32
Medtronic signs distribution agreement with Merit Medical for ViaVerte basivertebral nerve ablation system
Medtronic signs distribution agreement with Merit Medical for ViaVerte basivertebral nerve ablation system Medtronic signed a distribution agreement with Merit Medical to offer the FDA-cleared ViaVerte basivertebral nerve ablation system for chronic vertebrogenic lower-back pain. The ViaVerte system
03-24 20:31
新浪财经ESG：Merit Medical Systems MSCI（明晟）ESG评级调升至AA
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务，助力上市公司传播ESG理念，提升ESG可持续发展表现。点击查看【 ESG评级中...
03-24 10:25
Merit Medical Launches the Resilience Through-the-Scope Esophageal Stent
Merit Medical has launched the Resilience TTS Esophageal Stent, designed to treat esophageal fistulas and malignant strictures. The stent features an anti-migration system, unique sizes (14 mm, 17 mm, and 20 mm x 50 mm), and a user-friendly deployment system, addressing clinical challenges in esophageal cancer treatment. Esophageal cancer, a leading cause of cancer deaths, causes symptoms like difficulty swallowing and chest pain. The Resilience ...
03-16 13:25
美股大行评级 | 最高300美元！大摩、小摩、花旗纷纷上调英伟达目标价；赛富时、C3.ai、Snowflake、Trade Desk等遭数十家机构下调目标价
今日重点评级关注：HC Wainwright & Co.：维持NovoCure"买入"评级，目标价从47美元升至49美元；Citizens：维持Ironwood医药"跑赢大市"评级，目标价从8美元升至10美元
02-27 11:07
Wells Fargo Downgrades Merit Medical Systems to Equal-Weight, Lowers Price Target to $78
Wells Fargo analyst Larry Biegelsen downgrades Merit Medical Systems (NASDAQ:MMSI) from Overweight to Equal-Weight and lowers the price target from $95 to $78.
02-26 22:49
美股大行评级 | 大摩将应用材料目标价升至432美元；潜在涨幅200.0%！维尔生物科技获巴克莱升目标价至30美元，维持"超配"评级
今日重点评级关注：巴克莱：维持Vir Biotechnology"超配"评级，目标价从26美元升至30美元；巴克莱：维持Iovance Biotherapeutics"超配"评级，目标价从10美元升至11美元
02-26 09:30
财报速睇 | 美好医疗系统2025财年Q4营收3.94亿美元，同比增长10.9%；归母净利润0.38亿美元，同比增长36.0%
华盛资讯2月25日讯，美好医疗系统公布2025财年Q4业绩，公司Q4营收3.94亿美元，同比增长10.9%，归母净利润0.38亿美元，同比增长36.0%。
02-25 06:07
Earnings Scheduled For February 24, 2026
Companies Reporting Before The Bell • China Yuchai Intl (NYSE:CYD) is expected ...
02-24 19:11
美股大行评级 | 潜在涨幅216.49%！杰富瑞上调BioAge Labs目标价至62美元，评级升至"买入"
今日重点评级关注：杰富瑞：上调BioAge Labs评级至"买入"，目标价从9美元升至62美元；RBC Capital：维持COMPASS Pathways Plc Sponsored ADR"跑赢大市"评级，目标价从21美元升至22美元
02-19 16:21
